Effect of RANKL Inhibition by Denosumab on Serum Cholesterol in Postmenopausal Women with Osteoporosis

被引：0
|
作者：
Grazette, L. [1 ]
Daizadeh, N. [1 ]
Wang, A. [1 ]
Haller, C. [1 ]
Daniels, A. [1 ]
Siddhanti, S. [1 ]
Bolognese, M. A. [2 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] Bethesda Hlth Rsch Cntr, Bethesda, MD USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2010年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E211 / E211
页数：1
相关论文
共 50 条
  • [1] Effect of RANKL Inhibition by Denosumab on Serum Cholesterol in Postmenopausal Women with Osteoporosis.
    Bolognese, M. A.
    Daizadeh, N.
    Wang, A.
    Haller, C.
    Daniels, A.
    Siddhanti, S.
    Grazette, L.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [2] Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis
    Lasco, Antonino
    Morabito, Nunziata
    Basile, Giorgio
    Atteritano, Marco
    Gaudio, Agostino
    Giorgianni, Grazia Maria
    Morini, Elisabetta
    Faraci, Bianca
    Bellone, Federica
    Catalano, Antonino
    CALCIFIED TISSUE INTERNATIONAL, 2016, 98 (02) : 123 - 128
  • [3] Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis
    Antonino Lasco
    Nunziata Morabito
    Giorgio Basile
    Marco Atteritano
    Agostino Gaudio
    Grazia Maria Giorgianni
    Elisabetta Morini
    Bianca Faraci
    Federica Bellone
    Antonino Catalano
    Calcified Tissue International, 2016, 98 : 123 - 128
  • [4] Inhibition of the RANKL with denosumab has no effect on circulating markers of atherosclerosis in women with postmenopausal osteoporosis: a pilot study
    Cristiana Cipriani
    Sara Piemonte
    Luciano Colangelo
    Viviana De Martino
    Daniele Diacinti
    Federica Ferrone
    Valentina Piazzolla
    Valeria Fassino
    Luciano Nieddu
    Salvatore Minisola
    Jessica Pepe
    Endocrine, 2021, 71 : 199 - 207
  • [5] Inhibition of the RANKL with denosumab has no effect on circulating markers of atherosclerosis in women with postmenopausal osteoporosis: a pilot study
    Cipriani, Cristiana
    Piemonte, Sara
    Colangelo, Luciano
    De Martino, Viviana
    Diacinti, Daniele
    Ferrone, Federica
    Piazzolla, Valentina
    Fassino, Valeria
    Nieddu, Luciano
    Minisola, Salvatore
    Pepe, Jessica
    ENDOCRINE, 2021, 71 (01) : 199 - 207
  • [6] Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis
    M. R. McClung
    K. Lippuner
    M. L. Brandi
    J. R. Zanchetta
    H. G. Bone
    R. Chapurlat
    D. Hans
    A. Wang
    C. Zapalowski
    C. Libanati
    Osteoporosis International, 2017, 28 : 2967 - 2973
  • [7] Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis
    McClung, M. R.
    Lippuner, K.
    Brandi, M. L.
    Zanchetta, J. R.
    Bone, H. G.
    Chapurlat, R.
    Hans, D.
    Wang, A.
    Zapalowski, C.
    Libanati, C.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (10) : 2967 - 2973
  • [8] Denosumab: an antifracture therapy for postmenopausal women with osteoporosis
    Jiang, Xuezhi
    Schnatz, Peter F.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (02): : 117 - 119
  • [9] Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
    Min, Yong-Ki
    ENDOCRINOLOGY AND METABOLISM, 2015, 30 (01) : 19 - 26
  • [10] Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
    Cummings, Steven R.
    San Martin, Javier
    McClung, Michael R.
    Siris, Ethel S.
    Eastell, Richard
    Reid, Ian R.
    Delmas, Pierre
    Zoog, Holly B.
    Austin, Matt
    Wang, Andrea
    Kutilek, Stepan
    Adami, Silvano
    Zanchetta, Jose
    Libanati, Cesar
    Siddhanti, Suresh
    Christiansen, Claus
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 756 - 765
12345